Company intelligence / Profile preview

HepQuant

Denver, Colorado, United Stateshepquant.com ↗

Ownership: Private
Development stage: Commercial

Overview

HepQuant has developed and commercialized noninvasive, blood-based quantitative tests—most notably the HepQuant DuO Test—that assess liver health by measuring cholate uptake and blood flow. These tests provide a Disease Severity Index to help clinicians manage patients with advanced or chronic liver diseases. The technology is validated in multiple analytical and clinical studies, is available through a CLIA-certified lab, and is used both clinically and in biopharma trials[1][2][3].

Therapeutic areas: Gastroenterology
Modalities: Device (diagnostic test)Non-pharmacological therapy (quantitative diagnostic)
Industry: Metabolite Diagnostics

Drug pipeline

2 assets

HepQuant DuO

Commercial

Indications: Liver disease assessment

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborations with pharmaceutical industry for clinical trials support[1]Academic partnerships for research studies[1]

Beyond the preview

Go deeper on HepQuant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HepQuant.

Explore the full profile